Source:http://linkedlifedata.com/resource/pubmed/id/21295278
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0007589,
umls-concept:C0007600,
umls-concept:C0018787,
umls-concept:C0025914,
umls-concept:C0026809,
umls-concept:C0033414,
umls-concept:C0037083,
umls-concept:C0050668,
umls-concept:C0086418,
umls-concept:C0279266,
umls-concept:C0443268,
umls-concept:C0872076,
umls-concept:C1511938,
umls-concept:C1710082,
umls-concept:C2698650
|
pubmed:issue |
2
|
pubmed:dateCreated |
2011-2-7
|
pubmed:abstractText |
Efficient differentiation of embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) to a variety of lineages requires step-wise approaches replicating the key commitment stages found during embryonic development. Here we show that expression of PdgfR-? segregates mouse ESC-derived Flk-1 mesoderm into Flk-1(+)PdgfR-?(+) cardiac and Flk-1(+)PdgfR-?(-) hematopoietic subpopulations. By monitoring Flk-1 and PdgfR-? expression, we found that specification of cardiac mesoderm and cardiomyocytes is determined by remarkably small changes in levels of Activin/Nodal and BMP signaling. Translation to human ESCs and iPSCs revealed that the emergence of cardiac mesoderm could also be monitored by coexpression of KDR and PDGFR-? and that this process was similarly dependent on optimal levels of Activin/Nodal and BMP signaling. Importantly, we found that individual mouse and human pluripotent stem cell lines require optimization of these signaling pathways for efficient cardiac differentiation, illustrating a principle that may well apply in other contexts.
|
pubmed:grant | |
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1875-9777
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2011 Elsevier Inc. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
4
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
228-40
|
pubmed:meshHeading |
pubmed-meshheading:21295278-Activins,
pubmed-meshheading:21295278-Animals,
pubmed-meshheading:21295278-Bone Morphogenetic Proteins,
pubmed-meshheading:21295278-Cell Differentiation,
pubmed-meshheading:21295278-Flow Cytometry,
pubmed-meshheading:21295278-Humans,
pubmed-meshheading:21295278-Mice,
pubmed-meshheading:21295278-Myocytes, Cardiac,
pubmed-meshheading:21295278-Nodal Protein,
pubmed-meshheading:21295278-Pluripotent Stem Cells,
pubmed-meshheading:21295278-Reverse Transcriptase Polymerase Chain Reaction
|
pubmed:year |
2011
|
pubmed:articleTitle |
Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines.
|
pubmed:affiliation |
McEwen Center for Regenerative Medicine, University Health Network, Toronto, Ontario, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|